Preventing Cytomegalovirus Disease in Lung Transplant Recipients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the clinical outcomes related to Cytomegalovirus (CMV) in lung transplant recipients by monitoring their immunological responses to the virus. Participants will be followed to assess how their immune systems respond to CMV, particularly focusing on those with positive CMV IgG. The study will involve lung transplant candidates who are expected to undergo either single or double lung transplants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult patients over 18 years of age
2. Lung transplant candidates with positive CMV IgG
3. Anticipated to receive a lung transplant (both double lung and single lung)

Exclusion Criteria:

1. Negative CMV IgG prior transplant
2. Pregnant or breastfeeding women
3. HIV infected patients
4. Combined organ (e.g., lung-heart, lung-kidney) transplant candidates

Where it's running

• University of Miami
  Miami, Florida, United States Recruiting

Study contacts

• Principal investigator: Yoichiro Natori, MD — University of Miami
• Study coordinator: Yoichiro Natori, MD
• Email: yxn138@med.miami.edu
• Phone: 3053556323

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Electrical Impedance Tomography for Monitoring Lung Disease

  This test tries to see if a painless, noninvasive imaging method called electrical impedance tomography (EIT) can track how air is distributed in the lungs of adults with lung diseases and healthy volunteers and how those results match standard spirometry.

  Recruiting University Hospital Olomouc · Olomouc · NCT07356076

• Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD

  This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.

  Recruiting at 13 sites Phase 2 Pulmovant, Inc. · Santa Barbara, California and 12 other locations · NCT07333183

• Collecting lung sound recordings using Eko digital stethoscopes in clinic

  This project will try to teach computer programs to recognize wheeze, crackles, rhonchi, stridor, rales, and cough from stethoscope recordings in adults with suspected or diagnosed lung conditions and in people with normal lungs.

  Recruiting Eko Devices, Inc. · Mumbai, Maharashtra · NCT07270744

• Multi-omics prediction of graft problems after lung transplant

  We will test whether repeated blood and lung-fluid multi-omics tests can spot early graft dysfunction in adults after lung transplantation.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai · NCT07243964

• Recording lung sounds with Eko digital stethoscopes in clinic

  This project will test an AI that listens to lung sounds recorded with Eko digital stethoscopes to find abnormal sounds in people with or without lung disease.

  Recruiting at 2 sites Eko Devices, Inc. · Jacksonville, Florida and 1 other locations · NCT07227376

• Trop2- and EpCAM-targeted PET/CT to help distinguish non-small cell lung cancer

  This project will test whether PET/CT scans that target Trop2 and EpCAM can show protein expression in tumors of people with suspected non-small cell lung cancer.

  Recruiting RenJi Hospital · Shanghai · NCT07026110

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.